Please ensure Javascript is enabled for purposes of website accessibility
Gammora Logo

The Future of HIV Treatment

GAMMORA, developed by Code Pharma, prevents virus production by rapidly eliminating HIV-infected cells through controlled cell death and replacing them with healthy CD4 cells, as shown in clinical studies.

The treatment works by inserting a lab-produced harmless peptide that allows viral DNA fragments to integrate excessively. This causes infected cells to self-destruct while leaving healthy cells unaffected.

GAMMORA Antiviral Drug
GAMMORA Antiviral Drug
Play Video

Clinical Efficacy

Clinical studies demonstrate a clear reduction in latent HIV-infected cells and show Gammora’s ability to prevent virus production by rapidly eliminating infected cells through controlled cell death.

Gammora treatment has shown no unpleasant side effects, as its mechanism specifically targets HIV-infected cells while leaving healthy cells unscathed.

Play Video

Eliminating HIV infected cells leaving healthy cells unscathed.

The Mechanism

Gammora is a synthetic 16-amino-acid peptide derived from the HIV-1 integrase, first identified at the Hebrew University in Israel. This lab-produced peptide short-circuits a mechanism that normally prevents further penetration of viral DNA fragments, causing infected cells to self-destruct through apoptosis while leaving healthy cells unaffected. Unlike antiretrovirals that delay HIV DNA integration, Gammora eliminates HIV-infected cells and progressively replaces them with healthy CD4 cells, potentially leading to an AIDS cure rather than just managing it as a chronic illness.

Latest News & Media